AI 聊天
正在載入 ONTTF 的資料(首次造訪,需要幾秒鐘)。

Oxford Nanopore Technologies plc

ONTTF · OTC Markets OTCPK · USD

2.64 -0.26 (-8.97%)

收盤價: Oct 16, 2026, 4:00 PM EDT

市值
$2.58B
下次財報日期
Aug 19, 2026

Oxford Nanopore Technologies plc(ONTTF)股價、分析與資料

間隔:1D
正在載入K線和訊號…

內在價值

估值模型屬於 Pro 功能。登入或升級後可查看完整分析。

查看方案 →

分析師預測

股票預測 →

分析師預測無法取得

12個月目標價 · n/a 位分析師

分析師共識: n/a

您正在查看免費總覽

建立免費帳戶,探索更多關於此標的的研究資料。

財務表現

查看財務 →
營收 (ttm)
$235.0M

正在載入...

最新財報

已通報較預期YoY 變更
營收—n/an/a
EPS—n/an/a

下次財報

收盤後。

估計 · 升級 →

查看財報詳情 →

指標

買價
2.59
市值
2.58B
淨利(ttm)
-121M
0.87
-0.17
n/a
n/a
P/B (ttm)
4.55
P/S (ttm)
10.99
財報日期
Aug 19, 2026
賣價
2.75
成交量
2,000
20 日平均成交量
51,076
開盤價
2.68
前收盤價
2.90
當日區間
2.68 - 2.68
52 週範圍
1.27 - 3.18
股利
n/a
除息日
n/a

關於 Oxford Nanopore Technologies plc

查看公司資料 →
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom. Biotechnology · Healthcare

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

類股 Healthcare
IPO 日期 Oct 15, 2021
員工 1,314
證券交易所 OTC Markets OTCPK
股票代號 ONTTF